264 related articles for article (PubMed ID: 33546642)
1. Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience.
Guan Y; Xiong J; Pan M; Shi W; Li J; Zhu H; Gong X; Li C; Mei G; Liu X; Pan L; Dai J; Wang Y; Wang E; Wang X
BMC Cancer; 2021 Feb; 21(1):123. PubMed ID: 33546642
[TBL] [Abstract][Full Text] [Related]
2. Cyberknife
Telentschak S; Ruess D; Grau S; Goldbrunner R; von Spreckelsen N; Jablonska K; Treuer H; Kocher M; Ruge M
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2765-2773. PubMed ID: 33638006
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery (SRS) in high-grade glioma: judicious selection of small target volumes improves results.
Bokstein F; Blumenthal DT; Corn BW; Gez E; Matceyevsky D; Shtraus N; Ram Z; Kanner AA
J Neurooncol; 2016 Feb; 126(3):551-7. PubMed ID: 26603164
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
[TBL] [Abstract][Full Text] [Related]
7. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
[TBL] [Abstract][Full Text] [Related]
8. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas.
McKenzie JT; Guarnaschelli JN; Vagal AS; Warnick RE; Breneman JC
J Neurooncol; 2013 Jul; 113(3):403-9. PubMed ID: 23589034
[TBL] [Abstract][Full Text] [Related]
10. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
11. Treatment of recurrent high grade gliomas with hypofractionated stereotactic image-guided helical tomotherapy.
Kim B; Soisson E; Duma C; Chen P; Hafer R; Cox C; Cubellis J; Minion A; Plunkett M; Mackintosh R
Clin Neurol Neurosurg; 2011 Jul; 113(6):509-12. PubMed ID: 21392883
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated Radiosurgery Plus Bevacizumab for Locally Recurrent Brain Metastasis with Previously High-Dose Irradiation.
Guan Y; Wang C; Zhu H; Li J; Xu W; Sun L; Pan L; Dai J; Wang Y; Wang E; Wang X
World Neurosurg; 2020 Jan; 133():e252-e258. PubMed ID: 31505283
[TBL] [Abstract][Full Text] [Related]
13. Single-fraction versus hypofractionated stereotactic radiosurgery for medium-sized brain metastases of 2.5 to 3 cm.
Chon H; Yoon K; Lee D; Kwon DH; Cho YH
J Neurooncol; 2019 Oct; 145(1):49-56. PubMed ID: 31420793
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.
Minniti G; Scaringi C; De Sanctis V; Lanzetta G; Falco T; Di Stefano D; Esposito V; Enrici RM
J Neurooncol; 2013 Jan; 111(2):187-94. PubMed ID: 23129347
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.
Wuthrick EJ; Curran WJ; Camphausen K; Lin A; Glass J; Evans J; Andrews DW; Axelrod R; Shi W; Werner-Wasik M; Haacke EM; Hillman GG; Dicker AP
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):369-75. PubMed ID: 25104067
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.
Fogh SE; Andrews DW; Glass J; Curran W; Glass C; Champ C; Evans JJ; Hyslop T; Pequignot E; Downes B; Comber E; Maltenfort M; Dicker AP; Werner-Wasik M
J Clin Oncol; 2010 Jun; 28(18):3048-53. PubMed ID: 20479391
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of gamma knife radiosurgery in the salvage treatment of patients with recurrent high-grade glioma.
Elaimy AL; Mackay AR; Lamoreaux WT; Demakas JJ; Fairbanks RK; Cooke BS; Lamm AF; Lee CM
World Neurosurg; 2013 Dec; 80(6):872-8. PubMed ID: 23403349
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas.
Kong DS; Lee JI; Park K; Kim JH; Lim DH; Nam DH
Cancer; 2008 May; 112(9):2046-51. PubMed ID: 18338759
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection.
Elliott RE; Parker EC; Rush SC; Kalhorn SP; Moshel YA; Narayana A; Donahue B; Golfinos JG
World Neurosurg; 2011; 76(1-2):128-40; discussion 61-2. PubMed ID: 21839964
[TBL] [Abstract][Full Text] [Related]
20. [Results of salvage stereotactic radiosurgery in 14 patients with grade III or IV gliomas].
Noël G; Ben Ammar CN; Feuvret L; Valery CA; Cornu P; Boisserie G; Simon JM; Hasboun D; Tep B; Delattre JY; Sanson M; Baillet F; Mazeron JJ
Rev Neurol (Paris); 2004 May; 160(5 Pt 1):539-45. PubMed ID: 15269671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
